Castleark Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Sell |
3,140
-50,720
| -94% | -$5.1M | 0.01% | 243 |
|
|
2025
Q1 | $4.11M | Buy |
53,860
+1,080
| +2% | +$82.4K | 0.14% | 140 |
|
|
2024
Q4 | $3.64M | Buy |
52,780
+9,480
| +22% | +$654K | 0.13% | 162 |
|
|
2024
Q3 | $3.16M | Buy |
43,300
+26,640
| +160% | +$1.94M | 0.13% | 147 |
|
|
2024
Q2 | $1.12M | Buy |
+16,660
| New | +$1.12M | 0.05% | 200 |
|
|
2022
Q4 | – | Sell |
-228,410
| Closed | -$4.92M | – | 302 |
|
|
2022
Q3 | $4.92M | Buy |
228,410
+64,060
| +39% | +$1.38M | 0.27% | 89 |
|
|
2022
Q2 | $3.24M | Sell |
164,350
-4,370
| -3% | -$86.2K | 0.17% | 127 |
|
|
2022
Q1 | $3.97M | Buy |
+168,720
| New | +$3.97M | 0.17% | 130 |
|
|
2021
Q2 | – | Sell |
-209,103
| Closed | -$7.12M | – | 344 |
|
|
2021
Q1 | $7.12M | Buy |
209,103
+4,835
| +2% | +$165K | 0.26% | 108 |
|
|
2020
Q4 | $6.8M | Sell |
204,268
-42,900
| -17% | -$1.43M | 0.25% | 109 |
|
|
2020
Q3 | $7.94M | Buy |
247,168
+44,593
| +22% | +$1.43M | 0.31% | 98 |
|
|
2020
Q2 | $5.58M | Buy |
+202,575
| New | +$5.58M | 0.24% | 113 |
|
|
2019
Q3 | – | Sell |
-284,297
| Closed | -$7.28M | – | 363 |
|
|
2019
Q2 | $7.28M | Buy |
284,297
+35,895
| +14% | +$919K | 0.28% | 122 |
|
|
2019
Q1 | $7.22M | Buy |
+248,402
| New | +$7.22M | 0.27% | 123 |
|